Abstract: The present invention relates to the use of (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4?-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]-amino}-5,6,7,8-tetrahydroquinoline-2-carboxylic acid of formula (I), prefer-ably in form of one of its salts or solvates or hydrates, preferably (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4?-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]-amino}-5,6,7,8-tetrahydroquinoline-2-carboxylic acid in form of monohydrate (I) of formula (I-M-I) or (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4?-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)-ethyl]-amino}-5,6,7,8-tetrahydroquinoline-2-carboxylic acid inform of mono hydrate (II) of formula (I-M-II), in the inhalative treatment of cardiopulmonary and pulmonary disorders, such as pulmonary arterial hypertension (P AH), chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary hypertension (PH) associated with chronic lung disease (PH group 3) such as pulmonary hypertension in chronic obstructive pulmo

Abstract: A motion-based push activation power assist system for manual wheelchairs. The system uses motion-based measurements to determine when the user applies a push to the wheelchair handrims and brakes with the handrims. The push recognition activates a drive system that provides an assistive driving force-pulse to the wheelchair to reduce the demand on the user during propulsion. The brake recognition deactivates the power assist. The provided power assist is proportional to the sensed push and can be modulated to different proportional settings.

Abstract: A motion-based push activation power assist system for manual wheelchairs. The system uses motion-based measurements to determine when the user applies a push to the wheelchair handrims and brakes with the handrims. The push recognition activates a drive system that provides an assistive driving force-pulse to the wheelchair to reduce the demand on the user during propulsion. The brake recognition deactivates the power assist. The provided power assist is proportional to the sensed push and can be modulated to different proportional settings.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1, R1?, X1, B1, R2, R2?, B2, X2, R3, Z-M-Y, and Y1-M1-Z1 are as defined herein.

Abstract: In a graphics processing unit (GPU), receiving an input image comprising an array of pixels. Each pixel having a grayscale value from a range of N grayscale values. For each particular input patch of pixels of a set of input patches partitioning the input image and in parallel for each particular grayscale value the range, counting the number of pixels in the particular input patch having the particular grayscale value. In parallel for each particular input patch of pixels of a set of input patches partitioning the input image, creating an output image patch as an ordered sequence of N pixels, with the color value of the nth pixel in each corresponding output patch representing the count of pixels in the particular input patch having the nth grayscale value. Combining the output image patches into a single composite output image of N pixels, the pixel value of the nth pixel in the single composite output image corresponding to the count of pixels in the input image having the nth grayscale value.

Abstract: A method comprising receiving, at a first computing system, encrypted identifiers, performing, by the first computing system, a concealing operation on the encrypted identifiers to produce concealed encrypted identifiers, wherein the concealing operation conceals the encrypted identifiers from the first computing system and a second computing system but enables matching between the concealed encrypted identifiers, decrypting, by the second computing system, the concealed encrypted identifiers to produce concealed identifiers, analyzing, by the second computing system using one or more match rules, the concealed identifiers to generate one or more associations between the concealed identifiers, and generating, by the second computing system, one or more universal identifiers based on the one or more associations.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R, R1B, R1C, R2B, R2C, B1, W, X, Y, Z are defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating viral infections, diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1C, B1, R2A, and R2B are defined herein.

Abstract: Systems and techniques for facilitating automatically coordinated social buying are provided. In various embodiments, a processor can receive an electronic request from a merchant device, which identifies a team deal. In various aspects, the processor can access a plurality of transactional browsing histories that are recorded by a respectively corresponding plurality of monitorial browser extensions, with each monitorial browser extension being installed on a respectively corresponding client device. In various instances, the processor can execute a machine learning model on each transactional browsing history, thereby determining whether the transactional browsing history demonstrates interest in the team deal. In various cases, for each transactional browsing history that demonstrates interest in the team deal, the processor can invite a user of a client device corresponding to the transactional browsing history to participate in the team deal.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I), wherein R1, R1?, X1, B1, R2, R2?, B2, X2, R3, Z-M-Y, and Y1-M1-Z1 are as defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R, R1B, R1C, R2B, R2C, B1, W, X, Y, Z are defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating viral infections, diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1c, B1, R2A, and R2B are defined herein.

Abstract: In a graphics processing unit (GPU), receiving an input image comprising an array of pixels. Each pixel having a gray scale value from a range of N grayscale values. For each particular input patch of pixels of a set of input patches partitioning the input image and in parallel for each particular grayscale value the range, counting the number of pixels in the particular input patch having the particular grayscale value. In parallel for each particular input patch of pixels of a set of input patches partitioning the input image, creating an output image patch as an ordered sequence of N pixels, with the color value of the nth pixel in each corresponding output patch representing the count of pixels in the particular input patch having the nth grayscale value. Combining the output image patches into a single composite output image of N pixels, the pixel value of the nth pixel in the single composite output image corresponding to the count of pixels in the input image having the nth grayscale value.

Abstract: A DC monitoring system is configured to measure and analyze VFD (Variable Frequency Drive) operational characteristics. The VFD is configured to receive three-phase input power from a standardized source and to provide variable frequency three-phase output power to a three-phase motor. In some applications, the VFD and motor operate at a medium voltage. The VFD can include multiple inverter modules consisting of a DC section and switching section, also referred to as a multiple bus configuration. The DC monitoring system includes a measurement module coupled to each DC bus of the VFD, a data communication network, and a PQube monitoring device for transmitting data signals corresponding to voltage values of the VFD DC bus obtained in a medium voltage compartment to a low voltage compartment for processing and analysis. Processing of the data signals enables comparative and predictive analysis to determine early warning for possible capacitance failure in the VFD.

Abstract: In one example, a method includes performing various operations at a backup server. These operations may include receiving, from a node, a request for restoration of a cumulative backup that includes a plurality of partial backups that have been merged together, where the plurality of partial backups includes data from a group of one or more nodes, and the group includes the node. The method further includes checking the cumulative backup to determine whether or not the cumulative backup has been finalized, accessing the cumulative backup when it has been determined that the cumulative backup has been finalized, and restoring the cumulative backup to a target node.

Abstract: A motion-based push activation power assist system for manual wheelchairs. The system uses motion-based measurements to determine when the user applies a push to the wheelchair handrims and brakes with the handrims. The push recognition activates a drive system that provides an assistive driving force-pulse to the wheelchair to reduce the demand on the user during propulsion. The brake recognition deactivates the power assist. The provided power assist is proportional to the sensed push and can be modulated to different proportional settings.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I), wherein R1, R1?, X1, B1, R2, R2?, B2, X2, R3, Z-M-Y, and Y1-M1-Z1 are as defined herein.

Abstract: A motion-based push activation power assist system for manual wheelchairs. The system uses motion-based measurements to determine when the user applies a push to the wheelchair handrims and brakes with the handrims. The push recognition activates a drive system that provides an assistive driving force-pulse to the wheelchair to reduce the demand on the user during propulsion. The brake recognition deactivates the power assist. The provided power assist is proportional to the sensed push and can be modulated to different proportional settings.

Abstract: A motion-based push activation power assist system for manual wheelchairs. The system uses motion-based measurements to determine when the user applies a push to the wheelchair handrims and brakes with the handrims. The push recognition activates a drive system that provides an assistive driving force-pulse to the wheelchair to reduce the demand on the user during propulsion. The brake recognition deactivates the power assist. The provided power assist is proportional to the sensed push and can be modulated to different proportional settings.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1C, R1D, B1, R2A, R2B, R2C, R2D, and R2E are defined herein and Formula (II) wherein R1H, R1K, R1J, and R2L are defined herein.